This is not an abstract diagnostic question. The entrepreneur who treats depression as burnout by taking time off, and returns to work to find that nothing has changed, has wasted the recovery window and may have deepened the episode by confirming that the condition is resistant to their efforts. The entrepreneur who treats burnout as depression with antidepressants may mask the symptoms without addressing the environmental and neurobiological cause — producing apparent stability followed by relapse when medication is reduced or the same conditions resume.

The diagnostic distinction: why contextual specificity is the primary discriminating feature

The WHO’s ICD-11 classification explicitly distinguished burnout from depressive disorder on the basis that burnout is work-context specific while depression is pervasive across all life contexts. This is the most clinically useful single discriminating question: does the experience of exhaustion, emotional blunting, and reduced motivation lift when you are genuinely removed from the work context — on a real holiday, for several days, with no work-related stimulation? If yes, the presenting condition is more consistent with burnout, where the work environment is the primary driver and removing the driver allows partial recovery. If no — if the exhaustion, loss of pleasure, and cognitive impairment persist regardless of context — the presentation is more consistent with a depressive episode, where the neurobiological substrate is independent of the environmental trigger.

The phenomenological overlap is genuine and clinically significant. Both conditions present with exhaustion, reduced motivation, emotional blunting, withdrawal from relationships, cognitive impairment, and anhedonia — the inability to experience pleasure from activities that previously generated it. The overlap is why misidentification is so common, and why structured assessment using validated tools for both conditions is the most reliable available approach.

The neurological distinction: different profiles despite overlapping symptoms

Depression is primarily characterised by serotonergic dysfunction and hippocampal neurogenesis reduction — the biological substrate that antidepressants target. Burnout is primarily characterised by HPA axis dysregulation, prefrontal cortical thinning, and amygdala hyperactivation — a distinct neurological profile that the HPA recalibration research addresses. Schonfeld and Bianchi’s (2016) foundational review of the burnout-depression distinction confirmed that despite the phenomenological overlap, the biological signatures are sufficiently distinct to support differential treatment.

This neurological distinction is what makes the treatment error consequential. Antidepressant medication targets the serotonergic system. In burnout without concurrent depression, the serotonergic system is not the primary dysregulated system — the HPA axis is. An antidepressant that reduces the distress signal without addressing the HPA dysregulation and the environmental conditions producing it is treating a secondary neurochemical consequence rather than the primary mechanism. The symptom relief may be real; the underlying condition is unaddressed.

Conversely, the burnout recovery strategy — psychological detachment, sleep restoration, exercise, environmental change — addresses the HPA dysregulation and prefrontal depletion that burnout produces. In a depressive episode without concurrent burnout, the primary deficit is serotonergic and neuroplastic, not HPA-driven. Environmental change alone — the holiday, the reduced workload, the sabbatical — does not restore hippocampal neurogenesis or normalise monoamine neurotransmitter function. The person returns from the sabbatical still depressed, with the added conclusion that even this intervention did not work.

Why exercise treats both but through different mechanisms

Noetel et al.’s (2024) BMJ meta-analysis — the most comprehensive available synthesis of exercise as a treatment for depression — established that exercise at clinical doses is among the most effective available interventions for both burnout and depression, but through mechanistically different pathways.

For burnout, exercise recalibrates the HPA axis: regular aerobic exercise reduces the cortisol overproduction or blunted cortisol pattern of HPA dysregulation, and the acute cortisol release of exercise provides the episodic stress-and-recovery cycle that the HPA axis requires to recalibrate toward normal function. For depression, exercise increases BDNF — brain-derived neurotrophic factor — which drives the hippocampal neurogenesis reduction that depression involves, and normalises monoamine neurotransmitter function through the same mechanisms that antidepressants target pharmacologically.

The practical implication is that exercise is one of the few interventions that genuinely addresses both conditions rather than requiring an accurate initial diagnosis — which is why it belongs in the recovery protocol regardless of whether the presenting condition is burnout, depression, or the combination that the progression research documents.

The burnout-to-depression progression: when they become the same condition

Schonfeld and Bianchi’s (2016) review and the Leiter and Maslach longitudinal research documented the progression pathway that makes the distinction most clinically consequential. Severe, prolonged burnout that is untreated eventually produces the serotonergic and neuroplastic changes associated with depression — the sustained HPA overactivation and chronic neuroinflammation alter the neurochemical environment in ways that precipitate depressive episodes with their own distinct substrate and trajectory.

At this point, the original burnout and the resulting depressive episode are concurrent conditions requiring concurrent treatment approaches. The person who addresses only the environmental causes of burnout — changes the working conditions, takes extended time off — may find that the burnout resolves while the depressive episode persists, because the conditions that precipitated the depression no longer match the conditions maintaining it. The person who addresses only the depression pharmacologically may find that the depression remits while the HPA dysregulation of the underlying burnout continues to impair function.

This is the specific reason that clinical assessment using both a validated burnout measure and a validated depression measure is the most reliable available approach. The Maslach Burnout Inventory captures the three burnout dimensions — emotional exhaustion, depersonalisation, and reduced efficacy — with established norms. The PHQ-9 or Beck Depression Inventory captures the depressive symptom profile. The combination of both provides a more accurate picture of which mechanisms are active than either alone.

The practical self-assessment questions

The single most discriminating clinical question for the initial self-assessment is contextual specificity: does this lift when you are genuinely removed from work for several consecutive days? The answer is rarely perfectly clear, but a meaningful lift in mood, motivation, and cognitive function during genuine work absence is more consistent with burnout; the complete absence of lift is more consistent with depression or concurrent depression.

The second most discriminating question is anhedonia: are you unable to experience pleasure from activities that have nothing to do with work — from relationships, physical activity, food, music, or rest? Anhedonia that extends across all life domains and is not specifically connected to work is more consistent with depression. Anhedonia that is primarily connected to the work activities that previously generated motivation is more consistent with the dopaminergic depletion of burnout.

Both conditions require professional assessment if the severity warrants. This article provides the framework for understanding the distinction, not a clinical diagnosis.

Books worth reading on this

Undoing Depression by Richard O’Connor is the most accessible available clinical account of how depression operates and what recovery actually requires — covering the neurobiological substrate, the cognitive and behavioural patterns that maintain depressive episodes, and the specific interventions that address the condition rather than its symptoms. For the entrepreneur who is uncertain whether what they are experiencing is burnout, depression, or both, O’Connor’s specific account of the phenomenology of genuine depressive episodes provides the most practically useful available comparison point.

If the dynamics described here are significantly affecting your wellbeing, speaking with a psychologist is the right next step. UK: Samaritans (116 123, free, 24/7). Mind (0300 123 3393). BACP: bacp.co.uk/search/Therapists. Crisis Text Line — text HOME to 741741 (US, UK, Canada, Ireland). International: internationaltherapistdirectory.com.

This article is for educational and informational purposes only. Sources: Maslach, C., Schaufeli, W.B. & Leiter, M.P. (2001), Job Burnout, Annual Review of Psychology, 52, 397–422. Schonfeld, I.S. & Bianchi, R. (2016), Burnout and Depression: Two Entities or One?, Journal of Clinical Psychology, 72(1), 22–37. Leiter, M.P. & Maslach, C. (2005), Banishing Burnout, Jossey-Bass. Sonnentag, S. & Fritz, C. (2007), The Recovery Experience Questionnaire, Journal of Occupational Health Psychology, 12(3), 204–221. Noetel, M. et al. (2024), Effect of Exercise for Depression: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials, BMJ, 384, e075847. Golkar, A. et al. (2014), The Influence of Work-Related Chronic Stress on the Regulation of Emotion and on Functional Connectivity in the Brain, PLoS ONE, 9(9), e104550. Walker, M. (2017), Why We Sleep, Scribner. O’Connor, R. (2010), Undoing Depression, Little, Brown. Hari, J. (2018), Lost Connections, Bloomsbury.